# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: David Hume (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN012-SYN-TD
- Date: 1775-09-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Fiona Gallacher, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Runny nose, sore throat, and cough for three days during chemotherapy. **S**

## History of present illness

Mr. Hume is a 64-year-old man with stage IIIB sigmoid colon cancer, resected in June, who is on day 9 of his third 21-day cycle of adjuvant CAPOX (oxaliplatin given on day 1, capecitabine on days 1 to 14). Three days ago he developed a runny nose and scratchy throat, followed by a dry cough. He called the oncology triage line this morning, as his chemotherapy plan instructs, and was asked to be seen in primary care today with a blood count. His home temperatures have been 37.1 to 37.4 °C, checked twice daily, and he has not taken acetaminophen, so no fever has been masked. A home COVID-19 antigen test yesterday was negative. He is eating and drinking normally, has had two soft stools a day without diarrhea, no mouth sores, and no redness or peeling of his palms or soles. The cold tingling in his fingers after each oxaliplatin dose settles within five days, as before. A friend who visited last week had a cold. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago |
| Location | Nose, throat, and chest |
| Duration | Three days |
| Character | Clear nasal discharge, scratchy throat, dry cough |
| Severity | Mild; sleeping normally |
| Timing | Day 9 of the third CAPOX cycle |
| Context | Exposure to a visitor with a cold; on capecitabine |
| Modifying factors | Warm drinks help; no medicines taken |
| Associated signs and symptoms | No fever, chills, breathlessness, chest pain, diarrhea, mouth sores, or hand-foot symptoms |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever above 37.4 °C, chills, or rigors; usual chemotherapy tiredness |
| Ears, nose, mouth, and throat | Positive | Clear rhinorrhea and sore throat; no mouth ulcers, ear pain, or facial pain |
| Respiratory | Positive | Dry cough; no breathlessness, wheeze, sputum, or hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No nausea, vomiting, diarrhea, or abdominal pain |
| Genitourinary | Negative | No dysuria or frequency |
| Integumentary | Negative | No palmar or plantar redness, peeling, or blistering |
| Neurological | Positive | Brief cold-triggered tingling of the fingers after oxaliplatin, resolving between doses; no numbness at rest |

8 systems reviewed. **S**

## Current medications

- Capecitabine 500 mg oral tablet, four tablets (1749 mg, 1000 mg/m²) by mouth twice daily on days 1 to 14 of each 21-day cycle, four cycles **S**
- Oxaliplatin 130 mg/m² (260 mg) intravenous infusion on day 1 of each 21-day cycle, four cycles **S**
- Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea during chemotherapy **S**
- Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than eight a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/72 mmHg; pulse 84 bpm; respirations 16/min; temperature 37.3 °C; oxygen saturation 97% on room air; weight 81.6 kg; BMI 25.8 kg/m². All vital signs are synthetic.

White cell count: 4.6 10*3/uL; Absolute neutrophil count: 2.4 10*3/uL; Hemoglobin: 12.1 g/dL (low); Platelets: 156 10*3/uL. All results are synthetic.

## Change since baseline

- White cell count: 7.4 10*3/uL at baseline, 4.6 10*3/uL at this visit **S**
- Hemoglobin: 10.6 g/dL (low) at baseline, 12.1 g/dL (low) at this visit **S**
- Platelets: 438 10*3/uL (high) at baseline, 156 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well-appearing, comfortable, speaking easily |
| Ears, nose, and throat | Nasal mucosa red with clear discharge; pharynx mildly red without exudate; no oral mucositis |
| Neck | No tender or enlarged nodes |
| Respiratory | Unlabored; clear to auscultation; no crackles or wheeze |
| Cardiovascular | Regular rhythm, heart rate 84 |
| Abdomen | Laparoscopic port scars healed; soft and non-tender |
| Skin | Palms and soles normal |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral upper respiratory infection, without fever or neutropenia** (J06.9). Afebrile at 37.3 °C with a clear chest and normal oxygen saturation. White cell count 4.6 and absolute neutrophil count 2.4 exclude neutropenia, so this is not febrile neutropenia and antibiotics are not indicated. **S**
   - Supportive care: fluids, rest, saline nasal rinse, and honey for the cough.
   - Check his temperature before any acetaminophen dose so that a fever is not masked.
   - Repeat the home COVID-19 antigen test in 48 hours; call the same day if it is positive, because antiviral treatment would be considered after a drug-interaction check.
   - Call the oncology 24-hour line at once, and go to the emergency department if told to, for a temperature of 38.0 °C or higher, chills, or breathlessness.
2. **Stage IIIB sigmoid colon cancer on adjuvant CAPOX, cycle 3** (C18.7). No chemotherapy toxicity needing a dose change: no diarrhea, mucositis, or hand-foot syndrome, and the blood count allows treatment. **S**
   - Continue capecitabine to day 14 as prescribed; results and plan sent to the oncology team today, who agreed.
   - Stop capecitabine and call oncology if he develops four or more extra stools a day, mouth sores that stop him eating, or painful red palms or soles.

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 4.2025 (2025), National Comprehensive Cancer Network
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018), American Society of Clinical Oncology and Infectious Diseases Society of America
- Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016), American College of Physicians and Centers for Disease Control and Prevention

## Follow-up

- Oncology team updated today. Nurse telephone check in two days. Cycle 4 as scheduled if well. **S**
- Next scheduled visit 1775-10-19: review two weeks after completing adjuvant CAPOX and start of survivorship surveillance. **S**
